BioStock: Q3 report confirms steady progress for Iconovo

During Q2 and Q3, Iconovo took several steps to put more focus on business development, and the latest quarterly report shared by the Swedish inhalation company indicates that the moves have been paying off so far. Thanks to a strong sales performance along with several milestones achieved during Q3, analysts predict a significant upside in Iconovo’s share price.

Read the full article at biostock.se:

https://www.biostock.se/en/q3-report-confirms-steady-progress-for-iconovo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se